SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-019917
Filing Date
2024-05-15
Accepted
2024-05-15 16:31:34
Documents
78
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 957636
2 ex31-1.htm EX-31.1 18740
3 ex31-2.htm EX-31.2 18459
4 ex32-1.htm EX-32.1 7058
5 ex32-2.htm EX-32.2 7175
  Complete submission text file 0001493152-24-019917.txt   5675594

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE aim-20240331.xsd EX-101.SCH 47762
7 XBRL CALCULATION FILE aim-20240331_cal.xml EX-101.CAL 63175
8 XBRL DEFINITION FILE aim-20240331_def.xml EX-101.DEF 222646
9 XBRL LABEL FILE aim-20240331_lab.xml EX-101.LAB 389535
10 XBRL PRESENTATION FILE aim-20240331_pre.xml EX-101.PRE 312748
81 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 772572
Mailing Address 2117 SW HIGHWAY 484 OCALA FL 32801
Business Address 2117 SW HIGHWAY 484 OCALA FL 32801 352-448-7797
AIM ImmunoTech Inc. (Filer) CIK: 0000946644 (see all company filings)

IRS No.: 520845822 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-27072 | Film No.: 24951746
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)